The Academy of Finland has decided to award 1.2 million euros in funding to six Finnish projects involved in four European research consortia. The consortia have received funding through the ERA-PerMed 2019 call. ERA-PerMed is an ERA-NET cofund which is supported by 32 partners from 23 countries.
The objective of the second ERA-PerMed call is to advance personalised medicine by supporting pre-clinical and/or clinical research that incorporates computational components and that is coupled with ethical and legal perspectives and healthcare optimisation. The Finnish research teams funded through this call are interested to explore questions related to the personalised treatment of comorbidities associated with leukaemia, breast cancer, osteoarthritis and depression.
The next ERA PerMed call will be opened in January 2020. The Academy of Finland has earmarked 1.5 million euros to support Finnish researchers submitting successful applications to the call.
The projects that are now granted funding will be integrated in the pHealth (Personalised Health – From Genes to Society) Academy Programme. This programme is focused on the collection and application of genome and other personal health data to maintain and promote the individual’s health and to prevent and treat diseases.
More information and inquiries
- ERA-PerMed funding decisions
- ERA-PerMed website
- Personalised Health – From Genes to Society (pHealth) 2015-2021
- Programme Manager Heikki Vilen, tel. +358 29 533 5135, firstname.lastname(at)aka.fi
- Programme Manager Sara Illman, tel. +358 29 533 5119 firstname.lastname(at)aka.fi